On 15th April 2022, the US District Court for the District of Maryland ordered the Food and Drug Administration (FDA) to submit regular reports on the premarket tobacco product application (PMTA)’s review progress to the court. These updates only cover a certain number of applications, and do not cover all of the current PMTAs under review.
This report discusses the background to this decision, examines the timeline of these updates and provides analysis of the FDA’s progress.
“ US FDA under scrutiny: the latest reports on PMTA progress ”
Buy report request information:
“ US FDA under scrutiny: the latest reports on PMTA progress ”
We also invite you to enjoy our FREE TRIAL
Sign up to our platform and you will have access to our latest business and regulatory news analysis, which keeps you updated with the latest hot topics in the sector.
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the ECigIntelligence team.
LATEST ALERTS
Table of contents
